respectfully disagree. Southridge might be inclined to short at some point but it won't happen until we see .05+. This has a long way to go before that. Also, no way BMSN and ENTB merge. The potential merger partner, imo, is a private research company that will ultimately quickly trigger sale of entire thing to a large, listed biopharma. Getting in here is a smart play!! GLTA.